COMMUNIQUÉS West-GlobeNewswire

Zosano Announces Publication on Adhesive Dermally-Applied Microarray (ADAM™) Technology for the Delivery of Zolmitriptan in Migraine in Journal of Pharmaceutics

20/06/2018 - 14:30

Peer reviewed article evaluates effect of skin models on in vitro performance of ADAM FREMONT, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical- [...]

Alder BioPharmaceuticals® to Present New Data Further Highlighting Eptinezumab’s Efficacy Profile for Migraine Prevention at American Headache Society Meeting

20/06/2018 - 14:30

New eptinezumab data at two late-breaking sessions demonstrate efficacy that is sustained and further improved after repeat treatments BOTHELL, Wash., June 20, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ( [...]

Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma

20/06/2018 - 14:24

TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) (“Emblem” or the “Company”), is pleased to announce that its Board of Directors has approved the Company’s formation of a [...]

PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company

20/06/2018 - 14:15

Agreement for new Bluetooth thermometer and other topics discussed in interview with CEOLIVE.TV DELRAY BEACH, Fla., June 20, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences [...]

HealthEC Announces Beaumont Health as New Client for Population Health Management Solution

20/06/2018 - 14:00

Beaumont Cites Breadth of HealthEC’s Data Aggregation and Analytics Capabilities as Key Reasons for Joining Platform PISCATAWAY, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- HealthEC , which earned the highest overall vendor [...]

WishBone Medical, Inc. announces Randal R. Betz, M.D. as Chief Medical Officer

20/06/2018 - 14:00

WARSAW, Ind., June 20, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. is pleased to announce the appointment of Randal R. Betz, M.D. as Chief Medical Officer. Dr. Betz, on a part time consulting basis, will provide [...]

OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients

20/06/2018 - 14:00

BATON ROUGE, La., June 20, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Samumed Presents Clinical and Preclinical Data at European League Against Rheumatism (EULAR) 2018 Annual Congress

20/06/2018 - 14:00

Phase 2 data in osteoarthritis and preclinical data in tendinopathy and psoriasis demonstrated the emerging breadth of the Samumed pipeline in arthritis related diseases and in dermatology SAN DIEGO, June 20, 2018 ( [...]

Cianna Medical Showcased the SAVI SCOUT® Radar Breast Localization System at Premier Inc.’s Annual Breakthroughs Conference

20/06/2018 - 13:30

ALISO VIEJO, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Cianna Medical’s SAVI SCOUT ® Radar Breast Localization System is one of the medical innovations that was showcased in front of thousands of healthcare providers at [...]

Moleculin Receives Approval for Leukemia Clinical Trial

20/06/2018 - 13:30

HOUSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody

20/06/2018 - 13:30

NEW YORK, June 20, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) and Novimmune SA, today announced that the companies have entered into an exclusive global agreement to collaborate on the development and [...]

Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial

20/06/2018 - 13:30

– John Farnam appointed to newly created position of Chief Operating Officer – – Bridget Martell, M.D., and Blake Tomkinson, Ph.D., join as Vice Presidents of Clinical Development – – Registration-directed trial of [...]

Restoration Robotics™ to Sponsor and Participate in The Aesthetic Show™ 2018

20/06/2018 - 13:30

SAN JOSE, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today announced that the Company will be a Premier Sponsor, deliver multiple [...]

genedrive plc: Grant to develop and implement a point-of-care test in the NHS to avoid antibiotic-related hearing loss in newborn children

20/06/2018 - 13:00

For release: 20 June 2018 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the [...]

iTeos Therapeutics Completes $75 Million Series B Financing

20/06/2018 - 13:00

iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative next-generation immuno-oncology [...]

Orion Corporation: Managers' transactions - Nina Karvonen

20/06/2018 - 11:01

ORION CORPORATION MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]

Orion Corporation: Managers' transactions - Anne Karvonen

20/06/2018 - 10:46

ORION CORPORATION MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]

ObsEva Announces Pricing of Follow-on Public Offering

20/06/2018 - 08:50

Geneva, Switzerland and Boston, MA - June 20, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Solon Eiendom ASA : Primary insider notification

20/06/2018 - 08:31

(Oslo, Norway, June 19, 2018) UFI AS has today bought 74.688 shares in Solon Eiendom ASA at a price of NOK 29.7396 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]